These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29316384)

  • 1. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
    Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
    Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.
    Huang R; Huang D; Dai W; Yang F
    Mol Cell Biochem; 2015 Jun; 404(1-2):251-7. PubMed ID: 25772486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer.
    Zhou WB; Zhong CN; Luo XP; Zhang YY; Zhang GY; Zhou DX; Liu LP
    Biochem Biophys Res Commun; 2016 Feb; 470(4):838-44. PubMed ID: 26806308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
    Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
    Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
    Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
    Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
    Cao XP; Cao Y; Zhao H; Yin J; Hou P
    Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
    J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
    Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
    PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer.
    Han X; Cao Y; Wang K; Zhu G
    Biomed Pharmacother; 2016 Aug; 82():312-8. PubMed ID: 27470368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade.
    Flohr AM; Rogalla P; Bonk U; Puettmann B; Buerger H; Gohla G; Packeisen J; Wosniok W; Loeschke S; Bullerdiek J
    Histol Histopathol; 2003 Oct; 18(4):999-1004. PubMed ID: 12973668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.
    Pegoraro S; Ros G; Piazza S; Sommaggio R; Ciani Y; Rosato A; Sgarra R; Del Sal G; Manfioletti G
    Oncotarget; 2013 Aug; 4(8):1293-308. PubMed ID: 23945276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
    Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
    Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
    Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
    Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA1 protein expression in familial breast carcinoma patients.
    Chiappetta G; Ottaiano A; Vuttariello E; Monaco M; Galdiero F; Gallipoli A; Pilotti S; Jodice G; Siranoush M; Colombo M; Ripamonti CB; Pallante PL; Radice P; Fusco A
    Eur J Cancer; 2010 Jan; 46(2):332-9. PubMed ID: 19896837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer.
    Jun KH; Jung JH; Choi HJ; Shin EY; Chin HM
    Int J Surg; 2015 Dec; 24(Pt A):39-44. PubMed ID: 26537313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group A1 protein modulates autophagy in cancer cells.
    Conte A; Paladino S; Bianco G; Fasano D; Gerlini R; Tornincasa M; Renna M; Fusco A; Tramontano D; Pierantoni GM
    Cell Death Differ; 2017 Nov; 24(11):1948-1962. PubMed ID: 28777374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.
    Yuan S; Pan Q; Fu C; Bi Z
    Mol Cell Biochem; 2011 Sep; 355(1-2):281-7. PubMed ID: 21573994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
    Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
    Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
    Zou Y; Wang Y
    J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.